Dr. Leigh Revers presents to Breast Cancer Oncologists

Dr. Leigh Revers, Associate Director of the Master of Biotechnology Program, presented to breast cancer oncologists from across Canada this evening. The title of his presentation was "The Role and Implication of Subsequent Entry Biologics (SEBs) in the Treatment of HER2+ Breast Cancer Patients in Canada".